Viewing Study NCT06563869


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:40 PM
Study NCT ID: NCT06563869
Status: RECRUITING
Last Update Posted: 2024-08-21
First Post: 2024-08-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module